Norges Bank’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-396,977
| Closed | -$31.7M | – | 2288 |
|
|
2021
Q1 | $31.7M | Sell |
396,977
-208,385
| -34% | -$16.3M | 0.01% | 1266 |
|
|
2020
Q4 | $47.7M | Sell |
605,362
-154,518
| -20% | -$9.06M | 0.01% | 1004 |
|
|
2020
Q3 | $33.4M | Sell |
759,880
-125,349
| -14% | -$6.18M | 0.01% | 1091 |
|
|
2020
Q2 | $39.2M | Buy |
885,229
+283,539
| +47% | +$10.6M | 0.01% | 998 |
|
|
2020
Q1 | $21.6M | Buy |
601,690
+54,508
| +10% | +$3.1M | 0.01% | 1195 |
|
|
2019
Q4 | $38.8M | Sell |
547,182
-72,163
| -12% | -$5.23M | 0.01% | 1080 |
|
|
2019
Q3 | $46.3M | Sell |
619,345
-143,045
| -19% | -$12.1M | 0.01% | 911 |
|
|
2019
Q2 | $61.5M | Hold |
762,390
| – | – | 0.02% | 758 |
|
|
2019
Q1 | $51M | Hold |
762,390
| – | – | 0.02% | 853 |
|
|
2018
Q4 | $56.8M | Buy |
762,390
+24,603
| +3% | +$2.03M | 0.02% | 673 |
|
|
2018
Q3 | $67.9M | Buy |
737,787
+21,025
| +3% | +$2M | 0.02% | 669 |
|
|
2018
Q2 | $70.5M | Buy |
716,762
+46,628
| +7% | +$5.22M | 0.02% | 629 |
|
|
2018
Q1 | $74.7M | Buy |
670,134
+41,733
| +7% | +$4.68M | 0.03% | 592 |
|
|
2017
Q4 | $64.6M | Sell |
628,401
-33,127
| -5% | -$3.3M | 0.02% | 653 |
|
|
2017
Q3 | $62.3M | Buy |
661,528
+36,973
| +6% | +$2.92M | 0.02% | 660 |
|
|
2017
Q2 | $48.7M | Buy |
624,555
+135,907
| +28% | +$10.2M | 0.02% | 760 |
|
|
2017
Q1 | $39.1M | Sell |
488,648
-4,956
| -1% | -$394K | 0.02% | 872 |
|
|
2016
Q4 | $38.9M | Sell |
493,604
-62,879
| -11% | -$4.89M | 0.02% | 827 |
|
|
2016
Q3 | $41.4M | Buy |
556,483
+18,686
| +3% | +$1.36M | 0.02% | 728 |
|
|
2016
Q2 | $37M | Hold |
537,797
| – | – | 0.02% | 796 |
|
|
2016
Q1 | $38.4M | Buy |
537,797
+151,584
| +39% | +$9.51M | 0.02% | 754 |
|
|
2015
Q4 | $24M | Buy |
386,213
+23,650
| +7% | +$1.44M | 0.01% | 1051 |
|
|
2015
Q3 | $20.6M | Hold |
362,563
| – | – | 0.01% | 1113 |
|
|
2015
Q2 | $19.5M | Buy |
362,563
+97,354
| +37% | +$4.74M | 0.01% | 1212 |
|
|
2015
Q1 | $12.6M | Buy |
265,209
+126,100
| +91% | +$5.58M | 0.01% | 1510 |
|
|
2014
Q4 | $6.02M | Buy |
139,109
+11,468
| +9% | +$469K | ﹤0.01% | 1862 |
|
|
2014
Q3 | $4.39M | Buy |
127,641
+23,841
| +23% | +$842K | ﹤0.01% | 1955 |
|
|
2014
Q2 | $3.8M | Buy |
+103,800
| New | +$3.52M | ﹤0.01% | 2106 |
|
Norges Bank's CMD Position: Q2 2021 in Review
Norges Bank sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 396,977 shares — an estimated $31.7M sold.
Norges Bank first reported a position in CMD in Q2 2014 and held it in 28 quarters. The position peaked at $74.7M in Q1 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Norges Bank reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Norges Bank sold 396,977 Cantel Medical Corporation shares in Q2 2021, an estimated $31.7M.
- Norges Bank first reported a position in Cantel Medical Corporation in Q2 2014 and held it in 28 quarters.
- Norges Bank's Cantel Medical Corporation position peaked at $74.7M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Norges Bank's 13F filing for Q2 2021, filed 10 Aug 2021.